HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Al-Shahi, R. Articles by Stapf, C. Search for Related Content PubMed Articles by Al-Shahi, R. Articles by Stapf, C.

The Prognosis and Treatment of Arteriovenous Malformations of the Brain

^* Specialist Registrar in Neurology, Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK;
Assistant Professor of Neurology, Neurologie, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75475, PARIS cedex 10. France. E-mail: Rustam.Al-Shahi{at}ed.ac.uk

EXTRACT

INTRODUCTION

Despite the passage of a century and a half since the first description of a brain arteriovenous malformation (AVM) (Rokitansky 1846), and although the imaging of brain AVMs advances relentlessly (Fig. 1), we still need adequate studies of brain AVM prognosis and reliable evaluations of their treatment. Prospective, population-based studies of brain AVM prognosis are underway (Al-Shahi et al. 2003; Stapf et al. 2003b), and a randomized controlledtrial (RCT) of their treatment is planned (http://www.arubastudy.org), so this review aims to inform your management of adults with brain AVMs whilst the results of these studies are awaited. This review is based on two systematic reviews updated to 1 January 2005 (Al-Shahi & Warlow 2001; Al-Shahi & Warlow 2005), an authoritative narrative review (The Arteriovenous Malformation Study Group 1999) and North American practice guidelines (Ogilvy et al. 2001).

IMPORTANCE OF BRAIN AVMS

The prevalence of brain AVMs is ~18 per 100 ...

[PDF of this article]